Allen Poirson - 22 Jul 2021 Form 3 Insider Report for Cytek BioSciences, Inc. (CTKB)

Role
SVP Marketing and Corp. Dev.
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Allen Poirson
Issuer symbol
CTKB
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
3
Filing time
22 Jul 2021, 21:13:19 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTKB Common Stock 38,883 22 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTKB Stock Option (Right to Buy) 22 Jul 2021 Common Stock 1,116 $0.9200 Direct F1
holding CTKB Stock Option (Right to Buy) 22 Jul 2021 Common Stock 159,996 $4.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/12th of the shares subject to the option shall vest monthly over one year from July 24, 2020.
F2 The shares subject to the option vest as follows: 25% of the shares subject to the option vest on April 2, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.

Remarks:

Exhibit 24 - Power of Attorney